TY  - CONF

T1  - 411 Long term laboratory safety of dupilumab in patients aged 6 months to 5 years with moderate-to-severe atopic dermatitis

JO  - British Journal of Dermatology

UR  - http://dx.doi.org/10.1093/bjd/ljad162.032

PY  - 2023/06/20

AU  - Siegfried E

AU  - Cork MJ

AU  - Lockshin B

AU  - Boguniewicz M

AU  - Uppal S

AU  - Khokhar FA

AU  - Bansal A

AU  - Sierka D

AU  - Cyr S

ED  - 

DO  - DOI: 10.1093/bjd/ljad162.032

PB  - Oxford University Press (OUP)

VL  - 188

IS  - Supplement_3

Y2  - 2024/12/22

ER  -